Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian Centers

This trial is an observational study about combination antifungal therapy in hematologic patients with proven and probable invasive fungal infections (IFI).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fungal Infection Bacterial Infections and Mycoses Infections Mycoses

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital, Udine

Udine, 33100, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Haematologic patients with proven or probable IFI
Therapy with a combination of antifungal drugs

Exclusion criteria

Haematologic patients with possible IFI

Treatment and study plan

Primary outcomes

safety, efficacy and duration of therapy

Time frame: one year

Sponsors and collaborators

Lead sponsor

University Hospital, Udine, Italy

Other

Collaborators

Catholic University of the Sacred Heart

Registry information

Official study title

Seifem Observational Study of Antifungal Combination Therapy In Hematologic Italian Centers

Acronym: SEIFEM COMBO

Important dates

Study start: 2009
Primary completion: 2009
Study completion: 2010
First posted: May 21, 2009
Registry last updated: Jan 26, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed